Literature DB >> 16715200

Infection-associated encephalopathies: their investigation, diagnosis, and treatment.

N W S Davies1, M K Sharief, R S Howard.   

Abstract

Reduced level of consciousness is a common clinical finding in acutely sick patients. In the majority of cases a cause for the encephalopathy is readily identifiable,whilst in a minority the aetiology is more difficult to ascertain. Frequently the onset of encephalopathy is associated with, or follows, infection. The mechanisms through which infection leads to encephalopathy are diverse. They range from direct microbial invasion of the brain or its supporting structures, to remote, infection-triggered mechanisms such as acute disseminated encephalomyelitis. Most common however, is the encephalopathy caused through a remote effect of systemic sepsis-septic encephalopathy. This article discusses the clinical presentation and underlying pathogeneses of the acute encephalopathies associated with infection, aiming to aid both their recognition and treatment.

Entities:  

Mesh:

Year:  2006        PMID: 16715200     DOI: 10.1007/s00415-006-0092-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   6.682


  90 in total

1.  Lack of sensitivity of the latex agglutination test to detect bacterial antigen in the cerebrospinal fluid of patients with culture-negative meningitis.

Authors:  K Tarafdar; S Rao; R A Recco; M M Zaman
Journal:  Clin Infect Dis       Date:  2001-06-21       Impact factor: 9.079

2.  ENCEPHALOPATHY AND FATTY DEGENERATION OF THE VISCERA. A DISEASE ENTITY IN CHILDHOOD.

Authors:  R D REYE; G MORGAN; J BARAL
Journal:  Lancet       Date:  1963-10-12       Impact factor: 79.321

3.  Faecal peritonitis causes oedema and neuronal injury in pig cerebral cortex.

Authors:  M C Papadopoulos; F J Lamb; R F Moss; D C Davies; D Tighe; E D Bennett
Journal:  Clin Sci (Lond)       Date:  1999-05       Impact factor: 6.124

Review 4.  Cytokine-induced sickness behavior: mechanisms and implications.

Authors:  R Dantzer
Journal:  Ann N Y Acad Sci       Date:  2001-03       Impact factor: 5.691

Review 5.  Current concepts in Reye's syndrome.

Authors:  J F Glasgow; R Moore
Journal:  Br J Hosp Med       Date:  1993 Nov 17-Dec 14

6.  Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children.

Authors:  J L Hynson; A J Kornberg; L T Coleman; L Shield; A S Harvey; M J Kean
Journal:  Neurology       Date:  2001-05-22       Impact factor: 9.910

Review 7.  Herpesvirus infections of the CNS: MR findings.

Authors:  R D Tien; G J Felsberg; A K Osumi
Journal:  AJR Am J Roentgenol       Date:  1993-07       Impact factor: 3.959

8.  Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients.

Authors:  B Sköldenberg; M Forsgren; K Alestig; T Bergström; L Burman; E Dahlqvist; A Forkman; A Frydén; K Lövgren; K Norlin
Journal:  Lancet       Date:  1984-09-29       Impact factor: 79.321

9.  Neurologic manifestations and outcome of West Nile virus infection.

Authors:  James J Sejvar; Maryam B Haddad; Bruce C Tierney; Grant L Campbell; Anthony A Marfin; Jay A Van Gerpen; Aaron Fleischauer; A Arturo Leis; Dobrivoje S Stokic; Lyle R Petersen
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

10.  Viral encephalitis in England, 1989-1998: what did we miss?

Authors:  Katy L Davison; Natasha S Crowcroft; Mary E Ramsay; David W G Brown; Nick J Andrews
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

View more
  21 in total

1.  Serial computed tomography and magnetic resonance imaging findings of biphasic acute hemorrhagic leukoencephalitis localized to the brain stem and cerebellum.

Authors:  Nyoung Keun Lee; Byung Hoon Lee; Yoon Joon Hwang; Su Young Kim; Ji Young Lee; Mee Joo
Journal:  Jpn J Radiol       Date:  2011-04-26       Impact factor: 2.374

Review 2.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

3.  Multiphasic acute disseminated encephalomyelitis (ADEM) following influenza type A (swine specific H1N1).

Authors:  Dilan Athauda; Thomasin C Andrews; Paul A Holmes; Robin S Howard
Journal:  J Neurol       Date:  2011-10-14       Impact factor: 4.849

4.  Endotoxin-induced systemic inflammation activates microglia: [¹¹C]PBR28 positron emission tomography in nonhuman primates.

Authors:  Jonas Hannestad; Jean-Dominique Gallezot; Thomas Schafbauer; Keunpoong Lim; Tracy Kloczynski; Evan D Morris; Richard E Carson; Yu-Shin Ding; Kelly P Cosgrove
Journal:  Neuroimage       Date:  2012-07-06       Impact factor: 6.556

Review 5.  The neurology of solid organ transplantation.

Authors:  J David Avila; Saša Živković
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

6.  Acute hemorrhagic leukoencephalitis associated with autoimmune myopathy.

Authors: 
Journal:  J Vasc Interv Neurol       Date:  2014-11

Review 7.  Septic Encephalopathy.

Authors:  Chiara Robba; Ilaria Alice Crippa; Fabio Silvio Taccone
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-02       Impact factor: 5.081

8.  [Sepsis-associated Guillain-Barré syndrome].

Authors:  S Rehberg; H Freise; P Young; C Ertmer; B Ellger; H Van Aken; M Westphal
Journal:  Anaesthesist       Date:  2009-02       Impact factor: 1.041

9.  Role of endothelial nitric oxide synthase-derived nitric oxide in activation and dysfunction of cerebrovascular endothelial cells during early onsets of sepsis.

Authors:  Osamu Handa; Jancy Stephen; Gediminas Cepinskas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-22       Impact factor: 4.733

10.  Neurodegenerative evidence in mice brains with cecal ligation and puncture-induced sepsis: preventive effect of the free radical scavenger edaravone.

Authors:  Hiroki Yokoo; Seiichi Chiba; Kengo Tomita; Michinori Takashina; Hiroshi Sagara; Saburo Yagisita; Yasuo Takano; Yuichi Hattori
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.